Achieve Life Sciences (ACHV) Free Cash Flow (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Free Cash Flow data on file, last reported at -$6.9 million in Q1 2026.

• Quarterly Free Cash Flow rose 37.48% year-over-year to -$6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$45.3 million (down 27.48% YoY) and the FY2025 annual result came in at -$49.5 million, down 66.28% from the prior year.
• Free Cash Flow advanced to -$6.9 million in Q1 2026, from -$18.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$4.4 million in Q4 2023 to a low of -$18.0 million in Q4 2025.
• A 5-year average of -$8.7 million and a median of -$8.3 million in 2022 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 113.55% — and 2023, when it soared 60.78%.
• Tracing ACHV's Free Cash Flow over 5 years: stood at -$11.1 million in 2022, then soared by 60.78% to -$4.4 million in 2023, then tumbled by 110.27% to -$9.2 million in 2024, then plunged by 96.02% to -$18.0 million in 2025, then surged by 61.51% to -$6.9 million in 2026.
• The last three Free Cash Flow figures came in at -$6.9 million (Q1 2026), -$18.0 million (Q4 2025), and -$11.3 million (Q3 2025), per Business Quant data.